GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Accelerate Diagnostics Inc (STU:1A80) » Definitions » Cyclically Adjusted PB Ratio

Accelerate Diagnostics (STU:1A80) Cyclically Adjusted PB Ratio : 0.14 (As of Jun. 06, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Accelerate Diagnostics Cyclically Adjusted PB Ratio?

As of today (2024-06-06), Accelerate Diagnostics's current share price is €1.07. Accelerate Diagnostics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €7.58. Accelerate Diagnostics's Cyclically Adjusted PB Ratio for today is 0.14.

The historical rank and industry rank for Accelerate Diagnostics's Cyclically Adjusted PB Ratio or its related term are showing as below:

STU:1A80' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.1   Med: 15.72   Max: 42.43
Current: 0.15

During the past years, Accelerate Diagnostics's highest Cyclically Adjusted PB Ratio was 42.43. The lowest was 0.10. And the median was 15.72.

STU:1A80's Cyclically Adjusted PB Ratio is ranked better than
94.74% of 475 companies
in the Medical Devices & Instruments industry
Industry Median: 2.1 vs STU:1A80: 0.15

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Accelerate Diagnostics's adjusted book value per share data for the three months ended in Mar. 2024 was €-1.087. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €7.58 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Accelerate Diagnostics Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Accelerate Diagnostics's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerate Diagnostics Cyclically Adjusted PB Ratio Chart

Accelerate Diagnostics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.33 7.06 5.18 0.73 0.46

Accelerate Diagnostics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.74 0.88 0.64 0.46 0.12

Competitive Comparison of Accelerate Diagnostics's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Accelerate Diagnostics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Accelerate Diagnostics's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Accelerate Diagnostics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Accelerate Diagnostics's Cyclically Adjusted PB Ratio falls into.



Accelerate Diagnostics Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Accelerate Diagnostics's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1.07/7.58
=0.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accelerate Diagnostics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Accelerate Diagnostics's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-1.087/131.7762*131.7762
=-1.087

Current CPI (Mar. 2024) = 131.7762.

Accelerate Diagnostics Quarterly Data

Book Value per Share CPI Adj_Book
201406 12.993 100.560 17.026
201409 12.580 100.428 16.507
201412 11.989 99.070 15.947
201503 12.171 99.621 16.099
201506 9.850 100.684 12.892
201509 8.004 100.392 10.506
201512 23.854 99.792 31.499
201603 20.988 100.470 27.528
201606 18.252 101.688 23.653
201609 15.805 101.861 20.447
201612 14.320 101.863 18.525
201703 12.422 102.862 15.914
201706 22.863 103.349 29.152
201709 19.677 104.136 24.900
201712 18.017 104.011 22.827
201803 16.006 105.290 20.032
201806 15.016 106.317 18.612
201809 12.240 106.507 15.144
201812 9.300 105.998 11.562
201903 6.983 107.251 8.580
201906 4.222 108.070 5.148
201909 1.698 108.329 2.066
201912 -1.214 108.420 -1.476
202003 -3.776 108.902 -4.569
202006 -5.840 108.767 -7.075
202009 -7.394 109.815 -8.873
202012 -8.962 109.897 -10.746
202103 -9.359 111.754 -11.036
202106 -9.415 114.631 -10.823
202109 -5.203 115.734 -5.924
202112 -4.589 117.630 -5.141
202203 -7.503 121.301 -8.151
202206 -7.355 125.017 -7.753
202209 -1.018 125.227 -1.071
202212 -2.156 125.222 -2.269
202303 -3.631 127.348 -3.757
202306 -2.485 128.729 -2.544
202309 -2.263 129.860 -2.296
202312 -1.252 129.419 -1.275
202403 -1.087 131.776 -1.087

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Accelerate Diagnostics  (STU:1A80) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Accelerate Diagnostics Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Accelerate Diagnostics's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Accelerate Diagnostics (STU:1A80) Business Description

Traded in Other Exchanges
Address
3950 South Country Club Road, Suite 470, Tucson, AZ, USA, 85714
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.

Accelerate Diagnostics (STU:1A80) Headlines

No Headlines